Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
Muted movement reflects consolidation phase as investors await earnings triggers
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The investment case for health technology in India is frequently overstated in one direction and understated in another
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity is positioning its technologies as a connected engine for discovery
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Subscribe To Our Newsletter & Stay Updated
